Kuti Baruch

Company: ImmunoBrain Checkpoint

Job title: Head of R&D

Seminars:

Targeting the Peripheral Immune System as a Novel Therapeutic Approach in Alzheimer’s Disease 11:30 am

Targeting the PD-1/PD-L1 immune checkpoint pathway in Alzheimer’s disease, to portray a unique therapeutic approach, not limited to any specific pathologyassociated factor (e.g. amyloid or tau) Utilizing studies in amyloidosis and tauopathy mouse models to highlight that our therapeutic approach activates a common mechanism of action that starts with evoking a transient immune response in…Read more

day: Day Two

Panel Discussion: Targets for Neuroinflammation 10:00 am

An interactive session to allow speakers to discuss different methods of targeting neuroinflammation Delving into the successes and downfalls and different targets, and their effectivity for different neurodegenerative disease profiles Looking towards future targets for neuroinflammation for both neurodegeneration and neuropsychiatric disordersRead more

day: Day Two